Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Senzime AB ( (SE:SEZI) ) is now available.
Senzime AB has announced an extraordinary general meeting to be held on June 30, 2025, to approve a directed share issue. This strategic move aims to inject new capital into the company by issuing a maximum of 700,000 new shares, specifically directed to Adam Dahlberg, to strengthen its financial position and support its growth initiatives.
More about Senzime AB
Senzime AB operates in the medical technology industry, focusing on developing and marketing systems for patient monitoring. The company is known for its innovative solutions that enhance patient safety and optimize healthcare efficiency.
YTD Price Performance: -15.45%
Average Trading Volume: 182,324
Current Market Cap: SEK619.3M
For an in-depth examination of SEZI stock, go to TipRanks’ Stock Analysis page.